Stocks in Play

4/25/2018 - 10:53 AM EST - Medicenna Therapeutics Corp. : Announced that executives from the companywill present an overview of the Company at the Bloom Burton & Co. Healthcare Investor Conference, Wednesday, May 2 in Toronto. Medicenna Therapeutics Corp. shares T.MDNA are trading unchanged at $1.60.


4/25/2018 - 10:47 AM EST - ESSA Pharma Inc. : Has consolidated its issued and outstanding common shares on a basis of one post-Consolidation Common Share for every 20 pre-Consolidation Common Shares effective as of April 25. ESSA Pharma Inc. shares V.EPI are trading unchanged at $4.40.


4/25/2018 - 10:39 AM EST - Denison Mines Corp : Reported the expansion of the Huskie zone with the receipt of chemical assay ("U3O8 ") results from the Company's winter 2018 diamond drilling program on the 64.22% owned Waterbury Lake project. The winter drilling program involved 9,794 metres of diamond drilling in 19 drill holes, and was focused on 50-metre step-out drilling along strike and down-dip of the Huskie zone, as well as wider-spaced reconnaissance drilling to the west along the geological trend. The winter drilling program is part of a larger 14,400-metre drill program planned for Waterbury Lake in 2018, with the remainder to be completed during the summer months. Denison Mines Corp shares T.DML are trading unchanged at $0.60.


4/25/2018 - 10:34 AM EST - Zymeworks Inc. : Announced today that the abstract highlighting new data from the Company’s adaptive Phase 1 clinical trial for ZW25 has been selected for an oral presentation at the American Society of Clinical Oncology (ASCO) being held in Chicago from June 1 through 5. Zymeworks Inc. shares T.ZYME are trading up $0.22 at $16.08.


4/25/2018 - 9:59 AM EST - Integrity Gaming Corp. : Announced financial results for full-year ended December 31, 2017 (all amounts stated in U.S. dollars). The company reported a 9% growth in revenue, to $16.4 million in 2017 compared to $15.0 million in 2016. It also reported a net loss of $8.5 million, or $0.24 per share, for 2017, compared to $6.5 million, or $0.19 per share, for 2016. Integrity Gaming Corp. shares V.IGAM are trading unchanged at $0.27.


4/25/2018 - 9:54 AM EST - Ikkuma Resources Corp. : Reported its financial results for year ended December 31, 2017. Revenues totaled $8.3 million, compared to $10.6 million in the prior-year. Net loss came in at $34.1 million, compared to net loss of $8.9 million. Ikkuma Resources Corp. shares V.IKM are trading unchanged at $0.35.


4/25/2018 - 9:49 AM EST - YDreams Global Interactive Technologies Inc. : Is continuing to work on blockchain integration for the Arkave VR segment of YDreams. The team is working to incorporate the acceptance of crypto currencies within the Arkave ecosystem. YDreams is a member of the Hyperledger Foundation, which is uniting visionary companies such as Intel and IBM to create and establish the future of blockchain technology. YDreams Global Interactive Technologies Inc. shares V.YD are trading up $0.01 at $0.19.


4/25/2018 - 9:45 AM EST - Rambler Metals and Mining : Has now filed the full NI43-101 Technical Report for the Ming Copper-Gold Mine Project previously announced on March 5. Rambler Metals and Mining shares V.RAB are trading unchanged at $0.11.


4/25/2018 - 9:42 AM EST - Desert Lion Energy Inc. : Has delivered the first shipment of lithium concentrate product to the port of Walvis Bay in Namibia in accordance with the terms of its offtake agreement with Chinese lepidolite converter and offtake partner Jiangxi Jinhui Lithium Co. Limited. The first shipment is expected to be approximately 30,000 tonnes (t) of lithium concentrate material, which will generate gross revenues of approximately $3.8 million for the Company. Desert Lion Energy Inc. shares V.DLI are trading unchanged at $1.19.


4/24/2018 - 12:35 PM EST - Delivra Corp. : Announced the ability to treat pain directly with a topical version of Advil™ (ibuprofen). Testing for effects on joint pain and inflammation, topical Delivra-ibuprofen formulation offers long-term pain and swelling reduction compared to oral ibuprofen. Delivra Corp. shares V.DVA are trading up $0.015 at $0.37.